CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2004; 25(04): 30-31
DOI: 10.1055/s-0041-1733094
Selected Summary

Glutathione S-Transferase M1 polymorphism – A risk factor for hepatic venoocclusive disease in bone marrow transplantation

A srivastava
Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical, New Delhi-110029, India
,
B Poonkughali
Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical, New Delhi-110029, India
,
RV Shaji
Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical, New Delhi-110029, India
,
B George
Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical, New Delhi-110029, India
,
V Mathews
Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical, New Delhi-110029, India
,
M Chandy
Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical, New Delhi-110029, India
,
R Krishnamoorthy
Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical, New Delhi-110029, India
,
Jospeh Dominic
Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical, New Delhi-110029, India
› Author Affiliations


Publication History

Article published online:
28 March 2022

© 2004. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Jones RJ, Lee KSK, Beschorner WE, et al. Veno occlusive disease of the liver following bone marrow transplantation. Transplantation 1987;44:778-783.
  • 2 MacDonald GB, Sharma P, Mathews DE et al. Veno occlusive disease of the liver after bone marrow transplantation diagnosis, incidence and predisposing factors. Hepatology; 4:116-22.
  • 3 Ganem G, Saint Marc Girardin M.F. , Kuentz M, et al. Veno occlusive disease of the liver after allogenec bone marrow transplantation in man. Int. J Rad. Oncol Biol Phy 1988;14:879.
  • 4 Slattery JT, Kalhorn TF, McDonald GB, et al. Conditioning regimen dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human bone marrow transplant patients. J Clin Oncol 1996;14:1484-94.
  • 5 M Czervunski JP Gibbs, JT Slattery. Busulfan conjugation by glutatione S transferases a and p. Drug Metabol Disp 1996;24:1015-1019.
  • 6 Gibbs JP, Czerwinski M, Slattery JT. Busulphan glulathione conjugation catalysed by human liver cytosolic glulathione S-transfereases. Cancer Res 1996;56:3678-3681.
  • 7 Nelson HH, Wiencke JK, Chriatiani DC, et al. Ethnic difference in the prevalence of the homozygous deleted genotype of GST. Carcinogenesis 1995;16:1243-1245.